00http://fasb.org/us-gaap/2022#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent0001039065--06-302023Q3false16870050167271210001039065us-gaap:CommonStockMember2023-03-310001039065us-gaap:CommonStockMember2022-09-300001039065us-gaap:CommonStockMember2021-07-012022-03-310001039065us-gaap:RetainedEarningsMember2023-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001039065us-gaap:RetainedEarningsMember2022-12-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-3100010390652022-12-310001039065us-gaap:RetainedEarningsMember2022-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001039065us-gaap:RetainedEarningsMember2022-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001039065us-gaap:RetainedEarningsMember2021-12-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-3100010390652021-12-310001039065us-gaap:RetainedEarningsMember2021-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-12-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-06-300001039065us-gaap:EmployeeStockOptionMember2022-06-300001039065osis:ShareBasedEmployeeCompensationPlansMember2023-03-310001039065us-gaap:RestrictedStockUnitsRSUMember2022-06-300001039065osis:PerformanceBasedRestrictedStockUnitsMember2022-07-012023-03-310001039065osis:PerformanceBasedRestrictedStockUnitsMember2021-07-012022-03-3100010390652023-01-012023-03-310001039065us-gaap:FacilityClosingMember2022-06-300001039065us-gaap:EmployeeSeveranceMember2022-06-300001039065osis:ChargesRelatedToLitigationMember2022-06-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-01-012023-03-310001039065osis:OptoelectronicsAndManufacturingDivisionMember2022-07-012023-03-310001039065us-gaap:LeaseholdImprovementsMember2023-03-310001039065us-gaap:LandMember2023-03-310001039065us-gaap:FurnitureAndFixturesMember2023-03-310001039065us-gaap:EquipmentMember2023-03-310001039065us-gaap:ConstructionInProgressMember2023-03-310001039065us-gaap:ComputerSoftwareIntangibleAssetMember2023-03-310001039065us-gaap:ComputerEquipmentMember2023-03-310001039065us-gaap:BuildingAndBuildingImprovementsMember2023-03-310001039065osis:ComputerSoftwareImplementationInProcessMember2023-03-310001039065us-gaap:LeaseholdImprovementsMember2022-06-300001039065us-gaap:LandMember2022-06-300001039065us-gaap:FurnitureAndFixturesMember2022-06-300001039065us-gaap:EquipmentMember2022-06-300001039065us-gaap:ConstructionInProgressMember2022-06-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2022-06-300001039065us-gaap:ComputerEquipmentMember2022-06-300001039065us-gaap:BuildingAndBuildingImprovementsMember2022-06-300001039065osis:ComputerSoftwareImplementationInProcessMember2022-06-300001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-01-012023-03-310001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-07-012023-03-310001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2022-01-012022-03-310001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2021-07-012022-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012023-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-01-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-01-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2023-01-012023-03-310001039065us-gaap:IntersegmentEliminationMember2023-01-012023-03-310001039065us-gaap:CorporateNonSegmentMember2023-01-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2022-07-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2022-07-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2022-07-012023-03-310001039065us-gaap:IntersegmentEliminationMember2022-07-012023-03-310001039065us-gaap:CorporateNonSegmentMember2022-07-012023-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2022-01-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2022-01-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2022-01-012022-03-310001039065us-gaap:IntersegmentEliminationMember2022-01-012022-03-310001039065us-gaap:CorporateNonSegmentMember2022-01-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2021-07-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2021-07-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2021-07-012022-03-310001039065us-gaap:IntersegmentEliminationMember2021-07-012022-03-310001039065us-gaap:CorporateNonSegmentMember2021-07-012022-03-310001039065us-gaap:RetainedEarningsMember2023-01-012023-03-310001039065us-gaap:RetainedEarningsMember2022-01-012022-03-310001039065us-gaap:RetainedEarningsMember2021-07-012022-03-310001039065osis:HealthcareDivisionMember2023-01-012023-03-310001039065osis:HealthcareDivisionMember2022-07-012023-03-310001039065osis:ClassActionLitigationAndGovernmentInvestigationsMemberosis:OtherOperationalEfficiencyActivitiesMember2021-07-012022-03-310001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2022-07-012023-03-310001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-07-012023-03-310001039065us-gaap:RevolvingCreditFacilityMember2022-07-012023-03-310001039065osis:LettersOfCreditSubFacilityMember2022-03-310001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001039065us-gaap:RevolvingCreditFacilityMember2021-12-310001039065us-gaap:RevolvingCreditFacilityMember2023-03-310001039065osis:TermLoanMember2023-03-310001039065us-gaap:LineOfCreditMember2023-03-310001039065osis:LettersOfCreditSubFacilityMember2023-03-310001039065osis:ConvertibleSeniorNotesDue2022Member2023-01-012023-03-310001039065us-gaap:TrademarksMember2023-03-310001039065us-gaap:InProcessResearchAndDevelopmentMember2023-03-310001039065us-gaap:TrademarksMember2022-06-300001039065us-gaap:InProcessResearchAndDevelopmentMember2022-06-300001039065osis:SecurityDivisionMember2022-07-012023-03-310001039065osis:OptoelectronicsAndManufacturingDivisionMember2022-07-012023-03-310001039065osis:HealthcareDivisionMember2022-07-012023-03-310001039065osis:SecurityDivisionMember2023-03-310001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-03-310001039065osis:HealthcareDivisionMember2023-03-310001039065osis:SecurityDivisionMember2022-06-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2022-06-300001039065osis:HealthcareDivisionMember2022-06-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-03-310001039065us-gaap:PatentsMember2023-03-310001039065us-gaap:DevelopedTechnologyRightsMember2023-03-310001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2023-03-310001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-06-300001039065us-gaap:PatentsMember2022-06-300001039065us-gaap:DevelopedTechnologyRightsMember2022-06-300001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2022-06-300001039065us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-03-310001039065us-gaap:EmployeeStockOptionMember2022-07-012023-03-310001039065us-gaap:RestrictedStockUnitsRSUMember2023-03-310001039065us-gaap:EmployeeStockOptionMember2023-03-310001039065us-gaap:ForeignExchangeForwardMember2023-03-310001039065us-gaap:ForeignExchangeForwardMember2022-06-300001039065us-gaap:InterestRateSwapMember2023-03-310001039065us-gaap:InterestRateSwapMember2022-06-300001039065osis:ConvertibleSeniorNotesDue2022Member2017-02-280001039065osis:ConvertibleSeniorNotesDue2022Member2022-06-300001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-07-012023-03-310001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-07-012023-03-310001039065us-gaap:RevolvingCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2022-07-012023-03-310001039065us-gaap:ServiceMember2023-01-012023-03-310001039065us-gaap:ProductMember2023-01-012023-03-310001039065us-gaap:ServiceMember2022-07-012023-03-310001039065us-gaap:ProductMember2022-07-012023-03-310001039065us-gaap:ServiceMember2022-01-012022-03-310001039065us-gaap:ProductMember2022-01-012022-03-310001039065us-gaap:ServiceMember2021-07-012022-03-310001039065us-gaap:ProductMember2021-07-012022-03-310001039065osis:OneInternationalCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2023-01-012023-03-310001039065osis:OneCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2022-07-012023-03-310001039065osis:OneInternationalCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2022-01-012022-03-310001039065osis:OneCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-06-300001039065osis:OneInternationalCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-07-012022-03-3100010390652022-03-3100010390652021-06-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-01-012023-03-310001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-07-012023-03-310001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2022-01-012022-03-310001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-07-012022-03-310001039065osis:SecurityDivisionMember2023-01-012023-03-310001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-03-310001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2023-02-280001039065osis:PrivatelyHeldProviderOfIntelligentInspectionSensoryAndRecognitionSolutionsMember2022-02-280001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2023-02-012023-02-280001039065osis:ProviderOfBaggageAndParcelInspectionSystemsMember2022-12-012022-12-310001039065osis:PrivatelyHeldProviderOfTrainingSoftwareAndSolutionsMember2022-08-012022-08-310001039065osis:PrivatelyHeldSalesAndServicesCompanyMember2022-02-012022-02-280001039065osis:PrivatelyHeldProviderOfIntelligentInspectionSensoryAndRecognitionSolutionsMember2022-02-012022-02-280001039065us-gaap:CorporateMember2023-01-012023-03-310001039065osis:OtherOperationalEfficiencyActivitiesMember2023-01-012023-03-310001039065us-gaap:CorporateMember2022-07-012023-03-310001039065osis:SecurityDivisionMember2022-07-012023-03-310001039065osis:OtherOperationalEfficiencyActivitiesMember2022-07-012023-03-310001039065us-gaap:CorporateMember2022-01-012022-03-310001039065osis:SecurityDivisionMember2022-01-012022-03-310001039065osis:OtherOperationalEfficiencyActivitiesMember2022-01-012022-03-310001039065us-gaap:CorporateMember2021-07-012022-03-310001039065osis:SecurityDivisionMember2021-07-012022-03-310001039065osis:OtherOperationalEfficiencyActivitiesMember2021-07-012022-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-03-310001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-03-310001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2023-03-310001039065us-gaap:IntersegmentEliminationMember2023-03-310001039065us-gaap:CorporateNonSegmentMember2023-03-310001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2022-06-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2022-06-300001039065us-gaap:OperatingSegmentsMemberosis:HealthcareDivisionMember2022-06-300001039065us-gaap:IntersegmentEliminationMember2022-06-300001039065us-gaap:CorporateNonSegmentMember2022-06-300001039065osis:ConvertibleSeniorNotesDue2022Member2022-07-012023-03-310001039065osis:ConvertibleSeniorNotesDue2022Member2022-01-012022-03-310001039065osis:ConvertibleSeniorNotesDue2022Member2021-07-012022-03-310001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-03-310001039065us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-03-310001039065us-gaap:CostOfSalesMember2023-01-012023-03-310001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012023-03-310001039065us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012023-03-310001039065us-gaap:CostOfSalesMember2022-07-012023-03-310001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-03-310001039065us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-03-310001039065us-gaap:CostOfSalesMember2022-01-012022-03-310001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012022-03-310001039065us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012022-03-310001039065us-gaap:CostOfSalesMember2021-07-012022-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-01-012023-03-310001039065us-gaap:RetainedEarningsMember2022-07-012023-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-07-012023-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-01-012022-03-310001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2021-07-012022-03-310001039065srt:MinimumMemberosis:PerformanceBasedRestrictedStockUnitsMember2022-07-012023-03-310001039065srt:MaximumMemberosis:PerformanceBasedRestrictedStockUnitsMember2022-07-012023-03-310001039065us-gaap:RestrictedStockUnitsRSUMemberosis:ShareBasedEmployeeCompensationPlansMember2022-07-012023-03-310001039065us-gaap:FacilityClosingMember2023-03-310001039065us-gaap:EmployeeSeveranceMember2023-03-310001039065us-gaap:AcquisitionRelatedCostsMember2023-03-310001039065osis:ChargesRelatedToLitigationMember2023-03-310001039065us-gaap:CommonStockMember2022-07-012023-03-310001039065us-gaap:FacilityClosingMember2022-07-012023-03-310001039065us-gaap:EmployeeSeveranceMember2022-07-012023-03-310001039065us-gaap:AcquisitionRelatedCostsMember2022-07-012023-03-310001039065osis:ChargesRelatedToLitigationMember2022-07-012023-03-310001039065us-gaap:RevolvingCreditFacilityMember2021-12-012021-12-310001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2022-03-310001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-03-310001039065us-gaap:FairValueMeasurementsRecurringMember2023-03-310001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001039065us-gaap:FairValueMeasurementsRecurringMember2022-06-3000010390652022-01-012022-03-310001039065srt:ChiefExecutiveOfficerMemberus-gaap:DeferredBonusMember2017-12-012017-12-310001039065srt:ChiefExecutiveOfficerMemberus-gaap:DeferredBonusMember2017-12-310001039065osis:ConvertibleSeniorNotesDue2022Member2023-03-310001039065osis:ConvertibleSeniorNotesDue2022Member2022-09-0100010390652023-03-3100010390652022-06-3000010390652023-01-012023-03-3100010390652021-07-012022-06-3000010390652021-07-012022-03-3100010390652023-04-2500010390652022-07-012023-03-31xbrli:sharesiso4217:USDxbrli:pureosis:customeriso4217:USDxbrli:sharesosis:segment

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 000-23125

Graphic

OSI SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

33-0238801

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

12525 Chadron Avenue

Hawthorne, California 90250

(Address of principal executive offices) (Zip Code)

(310) 978-0516

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.001 par value

OSIS

The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

   

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

As of April 25, 2023, there were 16,727,882 shares of the registrant’s common stock outstanding.

Table of Contents

OSI SYSTEMS, INC.

INDEX

PAGE

PART I — FINANCIAL INFORMATION

3

Item 1 —

Financial Statements (Unaudited)

3

Condensed Consolidated Balance Sheets at June 30, 2022 and March 31, 2023

3

Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2022 and 2023

4

Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended March 31, 2022 and 2023

5

Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 31, 2022 and 2023

6

Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2022 and 2023

8

Notes to Condensed Consolidated Financial Statements

9

Item 2 —

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3 —

Quantitative and Qualitative Disclosures about Market Risk

30

Item 4 —

Controls and Procedures

30

PART II — OTHER INFORMATION

32

Item 1 —

Legal Proceedings

32

Item 1A —

Risk Factors

32

Item 2 —

Unregistered Sales of Equity Securities and Use of Proceeds

32

Item 3 —

Defaults Upon Senior Securities

32

Item 4 —

Mine Safety Disclosures

32

Item 5 —

Other Information

32

Item 6 —

Exhibits

33

Signatures

34

2

Table of Contents

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(amounts in thousands, except share amounts and par value)

June 30,

March 31, 

    

2022

    

2023

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$

64,202

$

65,622

Accounts receivable, net

 

307,973

 

300,663

Inventories

 

333,907

 

371,795

Prepaid expenses and other current assets

 

40,062

 

40,454

Total current assets

 

746,144

 

778,534

Property and equipment, net

 

109,684

 

109,139

Goodwill

 

336,357

 

346,716

Intangible assets, net

 

138,370

 

140,192

Other assets

 

112,595

 

108,722

Total assets

$

1,443,150

$

1,483,303

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:

Bank lines of credit

$

60,000

$

215,000

Current portion of long-term debt

 

244,575

 

8,080

Accounts payable

 

125,204

 

127,255

Accrued payroll and related expenses

 

46,379

 

48,287

Advances from customers

 

19,917

 

33,841

Other accrued expenses and current liabilities

 

117,879

 

117,950

Total current liabilities

 

613,954

 

550,413

Long-term debt

 

48,668

 

138,190

Deferred income taxes

 

11,112

 

11,794

Other long-term liabilities

 

130,992

 

115,989

Total liabilities

 

804,726

 

816,386

Commitments and contingencies (Note 10)

STOCKHOLDERS’ EQUITY:

Preferred stock, $0.001 par value— 10,000,000 shares authorized; no shares issued or outstanding

 

 

Common stock, $0.001 par value—100,000,000 shares authorized; issued and outstanding, 16,870,050 shares at June 30, 2022 and 16,727,121 shares at March 31, 2023

 

17

 

17

Retained earnings

 

663,869

 

693,576

Accumulated other comprehensive loss

 

(25,462)

 

(26,676)

Total stockholders’ equity

 

638,424

 

666,917

Total liabilities and stockholders’ equity

$

1,443,150

$

1,483,303

See accompanying notes to condensed consolidated financial statements.

3

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(amounts in thousands, except per share data)

Three Months Ended March 31, 

Nine Months Ended March 31, 

    

2022

    

2023

    

2022

    

2023

Net revenues:

Products

$

221,857

$

223,724

$

634,446

$

637,563

Services

 

68,620

 

79,165

 

211,969

 

228,994

Total net revenues

 

290,477

 

302,889

 

846,415

 

866,557

Cost of goods sold:

Products

 

150,311

 

156,534

 

432,277

 

458,197

Services

 

37,308

 

42,569

 

112,177

 

120,870

Total cost of goods sold

 

187,619

 

199,103

 

544,454

 

579,067

Gross profit

 

102,858

 

103,786

 

301,961

 

287,490

Operating expenses:

Selling, general and administrative

 

57,813

 

53,707

 

170,015

 

161,148

Research and development

 

15,150

 

14,852

 

44,944

 

43,848

Impairment, restructuring and other charges, net

 

1,469

 

890

 

4,810

 

4,366

Total operating expenses

 

74,432

 

69,449

 

219,769

 

209,362

Income from operations

 

28,426

 

34,337

 

82,192

 

78,128

Interest and other expense, net

 

(2,301)

 

(5,727)

 

(6,534)

 

(14,339)

Other income, net

27,373

27,373

Income before income taxes

 

53,498

 

28,610

 

103,031

 

63,789

Provision for income taxes

 

(10,763)

 

(6,802)

 

(21,447)

 

(14,392)

Net income

$

42,735

$

21,808

$

81,584

$

49,397

Earnings per share:

Basic

$

2.45

$

1.30

$

4.60

$

2.93

Diluted

$

2.41

$

1.27

$

4.52

$

2.88

Shares used in per share calculation:

Basic

 

17,417

 

16,809

 

17,734

 

16,858

Diluted

 

17,709

 

17,184

 

18,036

 

17,151

See accompanying notes to condensed consolidated financial statements.

4

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(amounts in thousands)

    

Three Months Ended March 31, 

Nine Months Ended March 31, 

    

2022

    

2023

    

2022

    

2023

Net income

$

42,735

$

21,808

$

81,584

$

49,397

Other comprehensive income (loss):

Foreign currency translation adjustment, net of tax

 

(1,981)

 

1,569

 

(4,907)

 

(3,309)

Net unrealized gain (loss) on investments and derivatives, net of tax

(1,430)

1,098

Other, net of tax

132

332

396

997

Other comprehensive income (loss)

(1,849)

471

(4,511)

(1,214)

Comprehensive income

$

40,886

$

22,279

$

77,073

$

48,183

See accompanying notes to condensed consolidated financial statements.

5

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

(amounts in thousands, except share data)

Three Months Ended March 31, 2022

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—December 31, 2021

 

17,643,903

$

30,909

$

606,647

$

(17,408)

$

620,148

Vesting of RSUs

 

6,027

 

 

 

 

Shares issued under employee stock purchase program

32,105

2,307

2,307

Stock-based compensation expense

 

 

6,898

 

 

 

6,898

Repurchase of common stock

(635,962)

(39,904)

(11,648)

(51,552)

Taxes paid related to net share settlement of equity awards

 

(2,220)

 

(193)

 

 

 

(193)

Net income

 

 

 

42,735

 

 

42,735

Other comprehensive loss

 

 

 

 

(1,849)

 

(1,849)

Balance—March 31, 2022

17,043,853

$

17

$

637,734

$

(19,257)

$

618,494

Three Months Ended March 31, 2023

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—December 31, 2022

 

16,819,609

$

2,530

$

672,371

$

(27,147)

$

647,754

Exercise of stock options

 

11,848

891

891

Vesting of RSUs

 

5,510

Shares issued under employee stock purchase program

30,652

2,072

2,072

Stock-based compensation expense

 

7,112

7,112

Repurchase of common stock

(138,469)

(12,362)

(603)

(12,965)

Taxes paid related to net share settlement of equity awards

 

(2,029)

(226)

(226)

Net income

 

21,808

21,808

Other comprehensive income

 

471

471

Balance—March 31, 2023

16,727,121

$

17

$

693,576

$

(26,676)

$

666,917

6

Table of Contents

Nine Months Ended March 31, 2022

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2021

 

17,854,110

$

105,724

$

548,842

$

(14,746)

$

639,820

Exercise of stock options

 

164,612

311

311

Vesting of RSUs

 

335,099

Shares issued under employee stock purchase program

 

60,065

4,297

4,297

Stock-based compensation expense

 

20,986

20,986

Repurchase of common stock

(1,117,258)

(85,184)

(11,648)

(96,832)

Taxes paid related to net share settlement of equity awards

 

(252,775)

(19,354)

(19,354)

Adoption of ASU 2020-06 for convertible notes

(26,763)

18,956

(7,807)

Net income

 

81,584

81,584

Other comprehensive loss

 

(4,511)

(4,511)

Balance—March 31, 2022

17,043,853

$

17

$

637,734

$

(19,257)

$

618,494

Nine Months Ended March 31, 2023

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2022

16,870,050

$

17

$

663,869

$

(25,462)

$

638,424

Exercise of stock options

19,614

1,330

1,330

Vesting of RSUs

312,038

Shares issued under employee stock purchase program

59,255

4,041

4,041

Stock-based compensation expense

21,528

21,528

Repurchase of common stock

(400,230)

(17,067)

(17,682)

(34,749)

Taxes paid related to net share settlement of equity awards

(133,606)

(9,832)

(2,008)

(11,840)

Net income

49,397

49,397

Other comprehensive loss

(1,214)

(1,214)

Balance—March 31, 2023

 

16,727,121

$

17

$

693,576

$

(26,676)

$

666,917

7

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(amounts in thousands)

Nine Months Ended March 31, 

    

2022

    

2023

CASH FLOWS FROM OPERATING ACTIVITIES

    

Net income

$

81,584

$

49,397

Adjustments to reconcile net income to net cash provided by operating activities, net of effects from acquisitions:

Depreciation and amortization

 

28,980

 

28,819

Stock-based compensation expense

 

20,986

 

21,528

Recovery of losses on accounts receivable

(3,836)

(4,890)

Deferred income taxes

1,448

 

942

Amortization of debt discount and issuance costs

 

1,045

196

Gain on sale of property and equipment

(27,373)

Other

 

(1,074)

 

(46)

Changes in operating assets and liabilities—net of business acquisitions:

Accounts receivable

 

10,613

 

13,248

Inventories

 

(53,766)

 

(37,860)

Prepaid expenses and other assets

 

8,010

 

(4,924)

Accounts payable

 

(11,000)

 

2,134

Accrued payroll and related expenses

(9,837)

2,151

Advances from customers

 

7,523

 

13,963

Other

 

(11,490)

 

(11,980)

Net cash provided by operating activities

 

41,813

 

72,678

CASH FLOWS FROM INVESTING ACTIVITIES

Acquisition of property and equipment

 

(10,293)

 

(12,691)

Proceeds from sale of property and equipment

32,304

309

Purchases of certificates of deposit

(2,201)

(4,940)

Proceeds from certificates of deposit

55

3,827

Acquisition of businesses, net of cash acquired

 

(14,132)

 

(4,616)

Payments for intangible and other assets

 

(12,320)

 

(12,275)

Net cash used in investing activities

 

(6,587)

 

(30,386)

CASH FLOWS FROM FINANCING ACTIVITIES

Net borrowings on bank lines of credit

 

73,000

 

155,000

Proceeds from long-term debt

 

50,285

 

100,654

Payments on long-term debt

 

(40,893)

 

(247,818)

Proceeds from exercise of stock options and employee stock purchase plan

 

4,608

 

5,371

Payments of contingent consideration

(1,671)

(3,668)

Repurchases of common stock

 

(96,832)

 

(34,749)

Taxes paid related to net share settlement of equity awards

 

(19,354)

 

(11,840)

Net cash used in financing activities

 

(30,857)

 

(37,050)

Effect of exchange rate changes on cash

 

(1,703)

 

(3,822)

Net change in cash and cash equivalents

 

2,666

 

1,420

Cash and cash equivalents—beginning of period

 

80,613

 

64,202

Cash and cash equivalents—end of period

$

83,279

$

65,622

Supplemental disclosure of cash flow information:

Cash paid, net during the period for:

Interest

$

5,851

$

14,648

Income taxes

$

9,964

$

15,769

See accompanying notes to condensed consolidated financial statements.

8

Table of Contents

OSI SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conjunction with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded in accordance with SEC rules and regulations and GAAP applicable to interim unaudited financial statements. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for audited annual financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments of a normal and recurring nature that are considered necessary for a fair presentation of the results for the interim periods presented. These unaudited condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 filed with the SEC. There have been no material changes to our significant accounting policies from those disclosed therein. The accompanying condensed consolidated balance sheet as of June 30, 2022 was derived from the Company's audited consolidated financial statements at that date. The results of operations for the three and nine months ended March 31, 2023 are not necessarily indicative of the operating results to be expected for the full 2023 fiscal year or any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales, costs of sales and expenses during the reporting period. The most significant of these estimates and assumptions for our company relate to contract revenue, fair values of assets acquired and liabilities assumed in business combinations, values for inventories reported at lower of cost or net realizable value, stock-based compensation expense, income taxes, accrued warranty costs, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Due to the inherent uncertainty involved in making estimates, our actual amounts reported in future periods could differ materially from these estimates.

Earnings Per Share Computations

We compute basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. We compute diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common shares and dilutive potential common shares outstanding during the period. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock unit awards under the treasury stock method.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Three Months Ended March 31, 

    

Nine Months Ended March 31, 

2022

    

2023

    

2022

    

2023

Net income available to common stockholders

$

42,735

$

21,808

$

81,584

$

49,397

Weighted average shares outstanding—basic

 

17,417

 

16,809

 

17,734

 

16,858

Dilutive effect of equity awards

 

292

 

375

 

302

 

293

Weighted average shares outstanding—diluted

 

17,709

 

17,184

 

18,036

 

17,151

Basic earnings per share

$

2.45

$

1.30

$

4.60

$

2.93

Diluted earnings per share

$

2.41

$

1.27

$

4.52

$

2.88

Shares excluded from diluted earnings per share due to their anti-dilutive effect

211

60

62

75

9

Table of Contents

Cash and Cash Equivalents

We consider all highly liquid investments with maturities of three months or less as of the acquisition date to be cash equivalents.

Our cash and cash equivalents totaled $65.6 million at March 31, 2023. Of this amount, approximately 81% was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in the United Kingdom, India, Singapore, Malaysia and Canada, and to a lesser extent in Mexico, Indonesia, Albania and Australia. We have cash holdings in financial institutions that exceed insured limits for such financial institutions; we mitigate this risk, however, by utilizing international financial institutions of high credit quality.

Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, insurance company contracts, accounts receivable, accounts payable, debt instruments, an interest rate swap contract and foreign currency forward contracts. The carrying values of financial instruments, other than long-term debt instruments and the interest rate swap contract, are representative of their fair values due to their short-term maturities. The carrying values of our long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates for financing available to us. The fair values of our foreign currency forward contracts were not significant as of June 30, 2022 and March 31, 2023.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Level 1 category includes assets and liabilities measured at quoted prices in active markets for identical assets and liabilities. The Level 2 category includes assets and liabilities measured from observable inputs other than quoted market prices. The Level 3 category includes assets and liabilities for which valuation inputs are unobservable and significant to the fair value measurement. Our contingent payment obligations related to acquisitions, which are further discussed in Note 10 to the condensed consolidated financial statements, are in the Level 3 category for valuation purposes.

The fair values of our financial assets and liabilities are categorized as follows (in thousands):

    

June 30, 2022

    

March 31, 2023

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets—Insurance company contracts

$

$

40,284

$

$

40,284

$

$

43,471

$

$

43,471

Assets – Interest rate swap contract

$

$

$

$

$

$

1,641

$

$

1,641

Liabilities—Convertible debt

$

$

242,302

$

$

242,302

$

$

$

$

Liabilities—Contingent consideration

$

$

$

28,212

$

28,212

$

$

$

20,060

$

20,060

Derivative Instruments and Hedging Activity

Our use of derivatives consists of foreign currency forward contracts and an interest rate swap agreement. The foreign currency forward contracts are utilized to partially mitigate certain balance sheet exposures or used as a net investment hedge to protect against potential changes resulting from short-term foreign currency fluctuations. These contracts have original maturities of up to three months. We also manage our risk to changes in interest rates using derivative instruments. We use fixed interest rate swaps to effectively convert a portion of the variable interest rate payments to fixed interest rate payments. We do not use hedging instruments for speculative purposes.

The net gains or losses from our foreign currency forward contracts, which are not designated as hedge instruments, are reported in the consolidated statements of operations. The amounts reported in the consolidated statements of operations for the three and nine months ended March 31, 2022 and 2023 were not significant. The fair value of our foreign currency forward contracts is estimated using a standard valuation model and market-based observable inputs over the contractual term. Unrealized gains are recognized as assets and unrealized losses are recognized as liabilities. As of June 30, 2022 and March 31, 2023, we held foreign currency forward contracts with notional amounts totaling $22.9 million and $19.8 million, respectively. Unrealized gains and losses from our foreign currency forward contracts as of March 31, 2022 and 2023 were not significant.

10

Table of Contents

The interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to our variable, Secured Overnight Financing Rate (“SOFR”) based debt. The interest rate swap matures in December 2026. The interest rate swap is considered an effective cash flow hedge, and as a result, the net gains or losses on such instrument are reported as a component of other comprehensive income (loss) in the consolidated financial statements and are reclassified as net income when the underlying hedged interest impacts earnings. A qualitative and quantitative assessment over the hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate that the hedge may no longer be highly effective.

As of June 30, 2022 and March 31, 2023, the notional amount of the derivative instruments designated as an interest rate swap hedge was $0 and $175 million, respectively. The fair value of the interest rate swap contract as of March 31, 2023 was $1.6 million and is recorded in Other assets within the condensed consolidated balance sheet.

The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:

    

Three Months Ended March 31, 

    

Nine Months Ended March 31, 

2022

    

2023

2022

    

2023

Total interest and other expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded

$

(2,301)

$

(5,727)

$

(6,534)

$

(14,339)

Gain (loss) recognized in other comprehensive income (loss)

 

 

(1,430)

 

 

1,098

Amount reclassified from accumulated other comprehensive income (loss) to interest expense, net

 

 

(558)

 

 

(587)

Recently Adopted Accounting Pronouncement

Contract Assets and Contract Liabilities from Revenue Contracts with Customers in a Business Combination

In October 2021, the FASB issued Accounting Standards Update 2021-08, an accounting standard update to improve the accounting for contract assets and contract liabilities from revenue contracts with customers in a business combination (Topic 805). This amendment improves comparability for both the recognition and measurement of acquired revenue contracts with customers at the date of and after a business combination. We adopted the new guidance effective January 1, 2022 using the prospective approach and applied the amendments to the business combinations that occurred during the year ended June 30, 2022 and the nine months ended March 31, 2023. The adoption of ASU 2021-08 did not have a material impact on our consolidated financial statements.

2. Business Combinations

Under Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), the acquisition method of accounting requires us to record assets acquired less liabilities assumed from an acquisition at their estimated fair values at the date of acquisition. Any excess of the total estimated purchase price over the estimated fair value of the net assets acquired should be recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, acquired technology, trade names, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions which are believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is up to one year from the acquisition date, as additional information that existed at the acquisition date becomes available for preliminary estimates, we may record adjustments to the preliminary assets acquired and liabilities assumed. Any adjustments subsequent to the conclusion of such measurement period are reflected in reported earnings.

Fiscal Year 2023 Business Acquisitions

In February 2023, we (through our Healthcare division) acquired a privately held provider of software and solutions for approximately $2.1 million plus up to $5 million in potential contingent consideration. The acquisition was financed with cash on hand.

Through our Security division, we acquired (i) in December 2022 certain assets of a provider of baggage and parcel inspection systems for approximately $1.6 million and (ii) in August 2022 a privately held provider of training software and solutions for approximately $1.9 million plus an immaterial amount of potential contingent consideration. These acquisitions were financed with cash on hand.

11

Table of Contents

Fiscal Year 2022 Business Acquisitions

In February 2022, we (through our Security division) acquired a privately held provider of intelligent inspection, sensory, and recognition solutions for approximately $14 million plus up to $25 million in potential contingent consideration. The acquisition was financed with cash on hand and borrowings under our revolving bank line of credit.

We (through our Security division) also acquired in February 2022 a privately held sales and services company for approximately $1.1 million, plus an immaterial amount of potential contingent consideration. The acquisition was financed with cash on hand.

These business acquisitions, individually and in aggregate, were not material to our consolidated financial statements. Accordingly, pro forma historical results of operations and other disclosures related to these businesses have not been presented.

3. Balance Sheet Details

The following tables set forth details of selected balance sheet accounts (in thousands):

June 30, 

March 31, 

Accounts receivable, net

    

2022

    

2023

Accounts receivable

$

326,849

$

314,121

Less allowance for doubtful accounts

 

(18,876)

 

(13,458)

Total

$

307,973

$

300,663

June 30, 

March 31, 

Inventories

    

2022

    

2023

Raw materials

$

213,290

$

233,458

Work-in-process

 

46,873

 

63,181

Finished goods

 

73,744

 

75,156

Total

$

333,907

$

371,795

June 30, 

March 31, 

Property and equipment, net

    

2022

    

2023

Land

$

15,028

$

15,676

Buildings, civil works and improvements

 

47,309

 

49,023

Leasehold improvements

 

11,599

 

13,924

Equipment and tooling

 

128,425

 

134,078

Furniture and fixtures

 

3,592

 

3,543

Computer equipment

 

21,208

 

23,061

Computer software

 

25,153

 

26,757

Computer software implementation in process

9,422

9,344

Construction in process

 

5,283

 

3,894

Total

 

267,019

 

279,300

Less accumulated depreciation and amortization

 

(157,335)

 

(170,161)

Property and equipment, net

$

109,684

$

109,139

Depreciation and amortization expense for property and equipment was $5.4 million and $4.9 million for the three months ended March 31, 2022 and 2023, respectively, and $16.0 million and $14.6 million for the nine months ended March 31, 2022 and 2023, respectively.

12

Table of Contents

4. Goodwill and Intangible Assets

The changes in the carrying value of goodwill by segment for the nine-month period ended March 31, 2023 were as follows (in thousands)

Optoelectronics

And

Security

Healthcare

Manufacturing

    

Division

    

Division

    

Division

    

Consolidated

Balance as of June 30, 2022

$

225,555

$

43,187

$

67,615

$

336,357

Goodwill acquired or adjusted during the period

 

5,659

 

5,050

 

 

10,709

Foreign currency translation adjustment

 

48

 

44

 

(442)

 

(350)

Balance as of March 31, 2023

$

231,262

$

48,281

$

67,173

$

346,716

Intangible assets consisted of the following (in thousands):